Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14071450
Abstract: Glioblastoma Multiforme (GBM) is a devastating disease with a low survival rate and few efficacious treatment options. The fast growth, late diagnostics, and off-target toxicity of currently used drugs represent major barriers that need to… read more here.
Keywords: selective nanomedicines; improved anti; multiforme selective; gbm ... See more keywords